<p>Maia Wealth LLC 在第二季度通过向美国证券交易委员会提交的最新 13F 文件收购了 Stryker Corporation (NYSE:SYK - 免费报告) 的新股份。该公司收购了 1,342 股医疗技术公司的股票，价值约为 531,000 美元。</p>
<ul>
<li>为什么内部人士正在抛售 Robinhood、Stryker 和 Mercury Systems 的股票？</li>
</ul>
<p>其他机构投资者最近也对该公司的持股进行了调整。先锋集团在第二季度将其在 Stryker 的持股提高了 1.3%。先锋集团目前拥有 33,500,571 股医疗技术公司的股票，价值 13,253,831,000 美元，此前在上个季度又购买了 440,607 股。Price T Rowe Associates Inc. MD 在第一季度将其在 Stryker 的持股增加了 9.2%。Price T Rowe Associates Inc. MD 目前拥有 12,131,218 股医疗技术公司的股票，价值 4,515,847,000 美元，此前在上个季度又购买了 1,021,496 股。Geode Capital Management LLC 在第二季度将其在 Stryker 的持股增加了 1.1%。Geode Capital Management LLC 目前拥有 7,393,611 股医疗技术公司的股票，价值 2,910,445,000 美元，此前在上个季度又购买了 79,654 股。高盛集团在第一季度将其在 Stryker 的持股提高了 13.1%。高盛集团目前拥有 2,252,895 股医疗技术公司的股票，价值 838,640,000 美元，此前在上个季度又购买了 261,058 股。最后，瑞银资产管理美洲有限公司的一个独立业务部门在第一季度将其在 Stryker 的持股提高了 4.2%。瑞银资产管理美洲有限公司的这个独立业务部门目前拥有 2,086,960 股医疗技术公司的股票，价值 776,871,000 美元，此前在上个季度又购买了 83,954 股。机构投资者持有该公司 77.09% 的股份。</p>
<h2>Stryker 的内部交易</h2>
<p>在其他新闻中，首席会计官 William E. Berry, Jr. 于 11 月 14 日星期五出售了 1,953 股公司的股票。股票以平均价格 365.49 美元出售，总价值 713,801.97 美元。出售后，首席会计官持有 2,833 股公司的股票，价值 1,035,433.17 美元。此次交易使其持股减少了 40.81%。该交易已在向美国证券交易委员会提交的文件中披露，文件可在美国证券交易委员会网站上查阅。此外，首席财务官 Preston Wendell Wells 于 11 月 20 日星期四出售了 165 股公司的股票。股票以平均价格 365.88 美元出售，总交易额为 60,370.20 美元。出售后，首席财务官持有 6,694 股公司的股票，价值 2,449,200.72 美元。此次交易使其持股减少了 2.41%。该销售的美国证券交易委员会文件提供了更多信息。内部人士在上个季度出售了价值 185,381,932 美元的 522,118 股公司股票。公司内部人士持有该公司 5.90% 的股份。</p>
<h2>Stryker 股票表现</h2>
<ul>
<li>小心死亡交叉：3 只股票触发了这一可怕信号</li>
</ul>
<p>NYSE:SYK 周四开盘价为 372.04 美元。该公司的市值为 1422.8 亿美元，市盈率为 49.28，市盈增长比率为 2.66，贝塔值为 0.94。该公司的 50 日简单移动平均线为 369.13 美元，200 日简单移动平均线为 380.49 美元。该公司的债务与股本比率为 0.70，流动比率为 1.78，速动比率为 1.06。Stryker Corporation 的一年低点为 329.16 美元，一年高点为 406.19 美元。</p>
<p>Stryker (NYSE:SYK - 获取免费报告) 最近于 10 月 30 日星期四发布了季度财报。该医疗技术公司报告季度每股收益为 3.19 美元，超出分析师一致预期的 3.13 美元，超出幅度为 0.06 美元。Stryker 的股本回报率为 23.94%，净利润率为 12.25%。该公司本季度的收入为 60.6 亿美元，而分析师预期为 60.4 亿美元。去年同期，该公司每股收益为 2.87 美元。该公司本季度的收入较去年同期增长了 10.2%。Stryker 已将其 2025 财年的指引设定为每股收益 13.500-13.600 美元。分析师平均预计 Stryker Corporation 本年度每股收益为 13.47 美元。</p>
<h2>华尔街分析师观点</h2>
<ul>
<li>如果你只能持有 3 项投资一生，请考虑这些</li>
</ul>
<p>几家研究公司最近对 SYK 发布了报告。Redburn Partners 在 9 月 18 日星期四对 Stryker 设置了 420.00 美元的目标价。巴克莱在 10 月 22 日星期三将 Stryker 的目标价从 443.00 美元提高至 453.00 美元，并给予该股票 “超配” 评级。Truist Financial 在 11 月 14 日星期五将 Stryker 的目标价从 392.00 美元提高至 400.00 美元，并给予该公司 “持有” 评级。Needham &amp; Company LLC 在 11 月 14 日星期五重申了 “买入” 评级，并将 Stryker 的目标价设定为 448.00 美元。最后，Weiss Ratings 在周二重新发布了 Stryker 的 “持有 (c+)” 评级。十三位研究分析师对该股票给予了买入评级，六位分析师对该公司给予了持有评级。根据 MarketBeat，Stryker 的平均评级为 “适度买入”，平均目标价为 434.37 美元。</p>
<p><strong>阅读我们对 Stryker 的最新分析</strong></p>
<h2>Stryker 公司简介</h2>
<p>(免费报告)</p>
<p>Stryker Corporation 作为一家医疗技术公司运营。该公司通过两个部门运营，分别是医疗外科和神经技术，以及骨科和脊柱。骨科和脊柱部门提供用于全关节置换的植入物，如髋关节、膝关节和肩关节，以及创伤和四肢手术。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们认为比 Stryker 更好的股票</li>
<li>现在值得购买的三只最佳金融科技股票</li>
<li>为什么黄金如此钟爱特朗普，就像特朗普钟爱黄金一样</li>
<li>ETF 会支付股息吗？你需要知道的事项</li>
<li>谷歌的 Gemini 3 让博通股价飙升：TPU 成为焦点</li>
<li>航空公司股票 - 现在值得购买的顶级航空公司股票</li>
<li>Palantir 不仅仅是在乘风 AI 热潮——它正在主导这一切</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Stryker 吗？</h2>
<p>在考虑 Stryker 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Stryker 并不在名单上。</p>
<p>虽然 Stryker 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

史赛克

<p>Maia Wealth LLC 在第二季度收购了 1,342 股史赛克公司的股票，价值 531,000 美元。其他机构投资者，包括先锋集团和普莱斯·T·罗威协会，也增加了他们在史赛克的股份。内部交易包括首席行政官 William E. Berry, Jr. 和首席财务官 Preston Wendell Wells 的股票出售。史赛克最近的财报显示，收入同比增长 10.2%，季度每股收益为 3.19 美元，超出分析师预期</p>

<p>Maia Wealth LLC acquired a new stake in shares of Stryker Corporation (NYSE:SYK - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 1,342 shares of the medical technology company's stock, valued at approximately $531,000.</p>
<div class="lb-trans"><p>Maia Wealth LLC 在第二季度通过向美国证券交易委员会提交的最新 13F 文件收购了 Stryker Corporation (NYSE:SYK - 免费报告) 的新股份。该公司收购了 1,342 股医疗技术公司的股票，价值约为 531,000 美元。</p>
</div><ul>
<li>Why Are Insiders Are Dumping Shares of Robinhood, Stryker, and Mercury Systems?</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么内部人士正在抛售 Robinhood、Stryker 和 Mercury Systems 的股票？</li>
</ul>
</div><p>Other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of Stryker by 1.3% during the second quarter. Vanguard Group Inc. now owns 33,500,571 shares of the medical technology company's stock valued at $13,253,831,000 after purchasing an additional 440,607 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in Stryker by 9.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,131,218 shares of the medical technology company's stock valued at $4,515,847,000 after buying an additional 1,021,496 shares during the last quarter. Geode Capital Management LLC increased its stake in Stryker by 1.1% in the 2nd quarter. Geode Capital Management LLC now owns 7,393,611 shares of the medical technology company's stock valued at $2,910,445,000 after buying an additional 79,654 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Stryker by 13.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,252,895 shares of the medical technology company's stock worth $838,640,000 after buying an additional 261,058 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Stryker by 4.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,086,960 shares of the medical technology company's stock worth $776,871,000 after buying an additional 83,954 shares during the last quarter. Institutional investors own 77.09% of the company's stock.</p>
<div class="lb-trans"><p>其他机构投资者最近也对该公司的持股进行了调整。先锋集团在第二季度将其在 Stryker 的持股提高了 1.3%。先锋集团目前拥有 33,500,571 股医疗技术公司的股票，价值 13,253,831,000 美元，此前在上个季度又购买了 440,607 股。Price T Rowe Associates Inc. MD 在第一季度将其在 Stryker 的持股增加了 9.2%。Price T Rowe Associates Inc. MD 目前拥有 12,131,218 股医疗技术公司的股票，价值 4,515,847,000 美元，此前在上个季度又购买了 1,021,496 股。Geode Capital Management LLC 在第二季度将其在 Stryker 的持股增加了 1.1%。Geode Capital Management LLC 目前拥有 7,393,611 股医疗技术公司的股票，价值 2,910,445,000 美元，此前在上个季度又购买了 79,654 股。高盛集团在第一季度将其在 Stryker 的持股提高了 13.1%。高盛集团目前拥有 2,252,895 股医疗技术公司的股票，价值 838,640,000 美元，此前在上个季度又购买了 261,058 股。最后，瑞银资产管理美洲有限公司的一个独立业务部门在第一季度将其在 Stryker 的持股提高了 4.2%。瑞银资产管理美洲有限公司的这个独立业务部门目前拥有 2,086,960 股医疗技术公司的股票，价值 776,871,000 美元，此前在上个季度又购买了 83,954 股。机构投资者持有该公司 77.09% 的股份。</p>
</div><h2>Insider Transactions at Stryker</h2>
<div class="lb-trans"><h2>Stryker 的内部交易</h2>
</div><p>In other news, CAO William E. Berry, Jr. sold 1,953 shares of the business's stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $365.49, for a total value of $713,801.97. Following the sale, the chief accounting officer owned 2,833 shares of the company's stock, valued at $1,035,433.17. The trade was a 40.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Preston Wendell Wells sold 165 shares of the company's stock in a transaction that occurred on Thursday, November 20th. The shares were sold at an average price of $365.88, for a total transaction of $60,370.20. Following the sale, the chief financial officer owned 6,694 shares in the company, valued at $2,449,200.72. The trade was a 2.41% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 522,118 shares of company stock worth $185,381,932 over the last quarter. Corporate insiders own 5.90% of the company's stock.</p>
<div class="lb-trans"><p>在其他新闻中，首席会计官 William E. Berry, Jr. 于 11 月 14 日星期五出售了 1,953 股公司的股票。股票以平均价格 365.49 美元出售，总价值 713,801.97 美元。出售后，首席会计官持有 2,833 股公司的股票，价值 1,035,433.17 美元。此次交易使其持股减少了 40.81%。该交易已在向美国证券交易委员会提交的文件中披露，文件可在美国证券交易委员会网站上查阅。此外，首席财务官 Preston Wendell Wells 于 11 月 20 日星期四出售了 165 股公司的股票。股票以平均价格 365.88 美元出售，总交易额为 60,370.20 美元。出售后，首席财务官持有 6,694 股公司的股票，价值 2,449,200.72 美元。此次交易使其持股减少了 2.41%。该销售的美国证券交易委员会文件提供了更多信息。内部人士在上个季度出售了价值 185,381,932 美元的 522,118 股公司股票。公司内部人士持有该公司 5.90% 的股份。</p>
</div><h2>Stryker Stock Performance</h2>
<div class="lb-trans"><h2>Stryker 股票表现</h2>
</div><ul>
<li>Beware the Death Cross: 3 Stocks Triggering This Spooky Signal</li>
</ul>
<div class="lb-trans"><ul>
<li>小心死亡交叉：3 只股票触发了这一可怕信号</li>
</ul>
</div><p>NYSE:SYK opened at $372.04 on Thursday. The company has a market capitalization of $142.28 billion, a P/E ratio of 49.28, a P/E/G ratio of 2.66 and a beta of 0.94. The business has a fifty day simple moving average of $369.13 and a two-hundred day simple moving average of $380.49. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.06. Stryker Corporation has a 1 year low of $329.16 and a 1 year high of $406.19.</p>
<div class="lb-trans"><p>NYSE:SYK 周四开盘价为 372.04 美元。该公司的市值为 1422.8 亿美元，市盈率为 49.28，市盈增长比率为 2.66，贝塔值为 0.94。该公司的 50 日简单移动平均线为 369.13 美元，200 日简单移动平均线为 380.49 美元。该公司的债务与股本比率为 0.70，流动比率为 1.78，速动比率为 1.06。Stryker Corporation 的一年低点为 329.16 美元，一年高点为 406.19 美元。</p>
</div><p>Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Thursday, October 30th. The medical technology company reported $3.19 EPS for the quarter, beating analysts' consensus estimates of $3.13 by $0.06. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The firm had revenue of $6.06 billion for the quarter, compared to analysts' expectations of $6.04 billion. During the same quarter in the prior year, the firm earned $2.87 EPS. The business's revenue for the quarter was up 10.2% compared to the same quarter last year. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. On average, analysts expect that Stryker Corporation will post 13.47 earnings per share for the current year.</p>
<div class="lb-trans"><p>Stryker (NYSE:SYK - 获取免费报告) 最近于 10 月 30 日星期四发布了季度财报。该医疗技术公司报告季度每股收益为 3.19 美元，超出分析师一致预期的 3.13 美元，超出幅度为 0.06 美元。Stryker 的股本回报率为 23.94%，净利润率为 12.25%。该公司本季度的收入为 60.6 亿美元，而分析师预期为 60.4 亿美元。去年同期，该公司每股收益为 2.87 美元。该公司本季度的收入较去年同期增长了 10.2%。Stryker 已将其 2025 财年的指引设定为每股收益 13.500-13.600 美元。分析师平均预计 Stryker Corporation 本年度每股收益为 13.47 美元。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><ul>
<li>If You Could Only Hold 3 Investments for Life, Consider These</li>
</ul>
<div class="lb-trans"><ul>
<li>如果你只能持有 3 项投资一生，请考虑这些</li>
</ul>
</div><p>Several research firms have recently issued reports on SYK. Redburn Partners set a $420.00 target price on Stryker in a report on Thursday, September 18th. Barclays boosted their price objective on Stryker from $443.00 to $453.00 and gave the stock an &#34;overweight&#34; rating in a research report on Wednesday, October 22nd. Truist Financial raised their target price on Stryker from $392.00 to $400.00 and gave the company a &#34;hold&#34; rating in a research report on Friday, November 14th. Needham &amp; Company LLC reiterated a &#34;buy&#34; rating and set a $448.00 target price on shares of Stryker in a research note on Friday, November 14th. Finally, Weiss Ratings reissued a &#34;hold (c+)&#34; rating on shares of Stryker in a report on Tuesday. Thirteen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, Stryker has an average rating of &#34;Moderate Buy&#34; and an average target price of $434.37.</p>
<div class="lb-trans"><p>几家研究公司最近对 SYK 发布了报告。Redburn Partners 在 9 月 18 日星期四对 Stryker 设置了 420.00 美元的目标价。巴克莱在 10 月 22 日星期三将 Stryker 的目标价从 443.00 美元提高至 453.00 美元，并给予该股票 “超配” 评级。Truist Financial 在 11 月 14 日星期五将 Stryker 的目标价从 392.00 美元提高至 400.00 美元，并给予该公司 “持有” 评级。Needham &amp; Company LLC 在 11 月 14 日星期五重申了 “买入” 评级，并将 Stryker 的目标价设定为 448.00 美元。最后，Weiss Ratings 在周二重新发布了 Stryker 的 “持有 (c+)” 评级。十三位研究分析师对该股票给予了买入评级，六位分析师对该公司给予了持有评级。根据 MarketBeat，Stryker 的平均评级为 “适度买入”，平均目标价为 434.37 美元。</p>
</div><p><strong>Read Our Latest Analysis on Stryker</strong></p>
<div class="lb-trans"><p><strong>阅读我们对 Stryker 的最新分析</strong></p>
</div><h2>Stryker Company Profile</h2>
<div class="lb-trans"><h2>Stryker 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.</p>
<div class="lb-trans"><p>Stryker Corporation 作为一家医疗技术公司运营。该公司通过两个部门运营，分别是医疗外科和神经技术，以及骨科和脊柱。骨科和脊柱部门提供用于全关节置换的植入物，如髋关节、膝关节和肩关节，以及创伤和四肢手术。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Stryker</li>
<li>The 3 Best Fintech Stocks to Buy Now</li>
<li>Why Gold Loves Trump as Much as Trump Loves Gold</li>
<li>Do ETFs Pay Dividends? What You Need to Know</li>
<li>Google's Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage</li>
<li>Airline Stocks - Top Airline Stocks to Buy Now</li>
<li>Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Stryker 更好的股票</li>
<li>现在值得购买的三只最佳金融科技股票</li>
<li>为什么黄金如此钟爱特朗普，就像特朗普钟爱黄金一样</li>
<li>ETF 会支付股息吗？你需要知道的事项</li>
<li>谷歌的 Gemini 3 让博通股价飙升：TPU 成为焦点</li>
<li>航空公司股票 - 现在值得购买的顶级航空公司股票</li>
<li>Palantir 不仅仅是在乘风 AI 热潮——它正在主导这一切</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=SYK"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Stryker Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Stryker 吗？</h2>
</div><p>Before you consider Stryker, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Stryker 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Stryker 并不在名单上。</p>
</div><p>While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Stryker 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Maia Wealth LLC 购入了史赛克公司$SYK 的新股